Clinical Trial Update: Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients [NA]

View source ↗

Summary

This clinical trial is evaluating silibinin in combination with concomitant chemoradiotherapy and maintenance temozolomide for newly diagnosed IDH-wildtype, STA…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• Idh-wildtype Glioblastoma

Drugs mentioned

• Silibinin (silibinin)
• Temozolomide (Temozolomide)

Snippet

Sponsor: Istituto Oncologico Veneto IRCCS | Conditions: Glioblastoma, IDH Wild-type and STAT3-positive Glioblastoma | NA | Status: RECRUITING